Use of Oxiris membrane in real-world clinical practice in critical care patients: a multicenter observational study.

ABSTRACT:

Background

To characterize current clinical practices and outcomes associated with the use of the extracorporeal blood purification (EBP) device Oxiris® in critically ill patients.

Methods

This was a prospective clinical registry database that analyzed patients treated with Oxiris®. Three different clusters of critically ill patients were identified: Group A-patients with chronic kidney disease and systemic inflammation who required postoperative support of renal function; Group B-patients requiring immunomodulation without definitive indications for renal support; Group C-patients with abdominal septic shock necessitating both postoperative renal support and immunomodulation. The primary endpoint was the comparison between mortality rates predicted by the Simplified Acute P

SUBMITTER: Villa G 

PROVIDER: S-EPMC12713267 | biostudies-literature | 2025 Dec

REPOSITORIES: biostudies-literature